# OPDIVO

NDC: 0003-3774
Generic name: nivolumab
Labeler / Manufacturer: E.R. Squibb & Sons, L.L.C.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20141222

FDA application: BLA125554

## Active ingredients

- NIVOLUMAB: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0003-3774"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-3774
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f570b9c4-6846-4de2-abfa-4d0a4ae4e394